SciSparc Ltd. (NASDAQ:SPRC – Get Free Report)’s share price traded down 3.8% during mid-day trading on Friday . The stock traded as low as $0.31 and last traded at $0.33. 202,624 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 3,741,648 shares. The stock had previously closed at $0.34.
SciSparc Stock Down 3.8 %
The stock’s 50 day moving average price is $0.47 and its 200 day moving average price is $0.35.
SciSparc Company Profile
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
Featured Stories
- Five stocks we like better than SciSparc
- Growth Stocks: What They Are, Examples and How to Invest
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
